Toshimitsu Uede

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 6 EPO patents. Top assignees: Gene Techno Science Co., Ltd., Hokkaido University, Astellas Pharma Gmbh. Active years: 2007-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshimitsu Uede. Retrieved from https://idiyas.com/inventor/toshimitsu-uede

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 44.4

CIPO Patents = 6

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 28(Granted Patents)

Location History:

Hokkaido, JP (2007 - 2015)
Sapporo, JP (2009 - 2019)

Company Filing History:

7 out of 11

Gene Techno Science Co., Ltd.

Chemo-Sero-Therapeutic Research Institute

patents

where one patent can have more than one assignee

Years Active: 2007-2019

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10370450 - Anti-DR6 antibodies and methods of immune regulation (2019-08-06),

2. 9040295 - Anti-human α9 integrin antibody and use thereof (2015-05-26),

3. 8901280 - Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same (2014-12-02),

4. 8614296 - Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof (2013-12-24),

5. 8461310 - Anti-ADAM-15 antibodies and utilization of the same (2013-06-11),

6. 8372639 - Anti-human α9 integrin antibody and use thereof (2013-02-12),

7. 8221754 - Antihuman α9 integrin antibody and use of the same (2012-07-17),

8. 7595045 - Anti-α9 integrin antibody and the use thereof (2009-09-29),

9. 7241873 - Recombinant anti-osteopontin antibody and use thereof (2007-07-10),

Title: Toshimitsu Uede: A Trailblazer in Tech Innovation.

Introduction:

Toshimitsu Uede is a renowned inventor hailing from Hokkaido, Japan. With a passion for innovation and a drive to push the boundaries of technology, he has left a lasting impact on the field of inventions.

Latest Patents:

Among his impressive portfolio of 9 patents, Uede's latest inventions focus on cutting-edge immune regulation agents. His patents, such as "Anti-DR6 antibodies and methods of immune regulation" and "Anti-human α9 integrin antibody and use thereof," showcase his dedication to advancing healthcare through novel therapies.

Career Highlights:

Throughout his career, Uede has made significant contributions to the technological landscape. Notably, he has been associated with esteemed organizations like Gene Techno Science Co., Ltd., and the National University Corporation Hokkaido University. His work reflects a deep understanding of immune system modulation and therapeutic antibody development.

Collaborations:

Uede has collaborated with talented individuals in his field, including coworkers like Shigeyuki Kon and Masashi Kanayama. Together, they have worked on groundbreaking projects that have shaped the future of healthcare innovation.

Conclusion:

In conclusion, Toshimitsu Uede's relentless pursuit of innovation and his groundbreaking patents in immune regulation and therapeutic antibodies solidify his status as a trailblazer in the world of technology. His legacy continues to inspire inventors worldwide to strive for excellence and push the boundaries of what is possible in the realm of inventions.

Profile summary based on public USPTO records.